138 related articles for article (PubMed ID: 12948027)
1. Novel polyester-polysaccharide nanoparticles.
Lemarchand C; Couvreur P; Besnard M; Costantini D; Gref R
Pharm Res; 2003 Aug; 20(8):1284-92. PubMed ID: 12948027
[TBL] [Abstract][Full Text] [Related]
2. Physico-chemical characterization of polysaccharide-coated nanoparticles.
Lemarchand C; Gref R; Lesieur S; Hommel H; Vacher B; Besheer A; Maeder K; Couvreur P
J Control Release; 2005 Nov; 108(1):97-111. PubMed ID: 16169626
[TBL] [Abstract][Full Text] [Related]
3. Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins.
Rodrigues JS; Santos-Magalhães NS; Coelho LC; Couvreur P; Ponchel G; Gref R
J Control Release; 2003 Sep; 92(1-2):103-12. PubMed ID: 14499189
[TBL] [Abstract][Full Text] [Related]
4. Study of emulsion stabilization by graft copolymers using the optical analyzer Turbiscan.
Lemarchand C; Couvreur P; Vauthier C; Costantini D; Gref R
Int J Pharm; 2003 Mar; 254(1):77-82. PubMed ID: 12615414
[TBL] [Abstract][Full Text] [Related]
5. Emulsifying properties of biodegradable polylactide-grafted dextran copolymers.
Raynaud J; Choquenet B; Marie E; Dellacherie E; Nouvel C; Six JL; Durand A
Biomacromolecules; 2008 Mar; 9(3):1014-21. PubMed ID: 18271550
[TBL] [Abstract][Full Text] [Related]
6. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems.
Lemarchand C; Gref R; Passirani C; Garcion E; Petri B; Müller R; Costantini D; Couvreur P
Biomaterials; 2006 Jan; 27(1):108-18. PubMed ID: 16118015
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
[TBL] [Abstract][Full Text] [Related]
8. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of hydrophobically modified dextrans as potential drug carrier systems.
Aumelas A; Serrero A; Durand A; Dellacherie E; Leonard M
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):74-80. PubMed ID: 17560095
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable nanoparticles made from polylactide-grafted dextran copolymers.
Nouvel C; Raynaud J; Marie E; Dellacherie E; Six JL; Durand A
J Colloid Interface Sci; 2009 Feb; 330(2):337-43. PubMed ID: 19022457
[TBL] [Abstract][Full Text] [Related]
11. Poly(3-hydroxybutyrate-co-epsilon-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-epsilon-caprolactone) terpolymers as novel materials for colloidal drug delivery systems.
Pignatello R; Musumeci T; Impallomeni G; Carnemolla GM; Puglisi G; Ballistreri A
Eur J Pharm Sci; 2009 Jun; 37(3-4):451-62. PubMed ID: 19504659
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of Me. PEG-PLA copolymer nanoparticles prepared by modified spontaneous emulsion-solvent evaporation].
Dong J; Liu MX; Yang YJ; Xu HB; Yang XL
Yao Xue Xue Bao; 2004 Sep; 39(9):677-80. PubMed ID: 15606012
[TBL] [Abstract][Full Text] [Related]
13. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
Papadimitriou S; Bikiaris D
J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
[TBL] [Abstract][Full Text] [Related]
14. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
15. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of PEO-PCL-PEO triblock copolymers: effects of the PCL chain length on the physical property of W(1)/O/W(2) multiple emulsions.
Cho HK; Cho KS; Cho JH; Choi SW; Kim JH; Cheong IW
Colloids Surf B Biointerfaces; 2008 Aug; 65(1):61-8. PubMed ID: 18400473
[TBL] [Abstract][Full Text] [Related]
17. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique.
Quintanar-Guerrero D; Ganem-Quintanar A; Allémann E; Fessi H; Doelker E
J Microencapsul; 1998; 15(1):107-19. PubMed ID: 9463812
[TBL] [Abstract][Full Text] [Related]
18. On the use of tert-butanol/water cosolvent systems in production and freeze-drying of poly-ε-caprolactone nanoparticles.
Zelenková T; Barresi AA; Fissore D
J Pharm Sci; 2015 Jan; 104(1):178-90. PubMed ID: 25421731
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers.
Yu H; Wang W; Chen X; Deng C; Jing X
Biopolymers; 2006 Oct; 83(3):233-42. PubMed ID: 16761262
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
Abdelwahed W; Degobert G; Fessi H
Int J Pharm; 2006 Feb; 309(1-2):178-88. PubMed ID: 16326053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
